Ms Gertie Lintjens > CMS > Amsterdam, Netherlands > Lawyer Profile

CMS
ATRIUM
PARNASSUSWEG 737
1077 DG AMSTERDAM
Netherlands

Work Department

Life Sciences & Healthcare

Position

Of Counsel

Career

Gertie Lintjens is a Life Sciences expert who has more than 25 years of experience working as in-house counsel, predominately in the Life Sciences industry. After being appointed a judge trainee in 1996, she has pursued her career in 1998 as an in-house counsel. She held senior international legal positions in global companies like Heinz and Eli Lilly and has been general counsel of myTomorrowsan online platform that enables access to drugs in development.

Based on her unique insight into the Life Sciences industry she advises clients that are active in the field of pharmaceuticals and medical devices on a broad range of legal and compliance matters, including advertising and promotion, pricing and reimbursement, early access schemes, clinical research, patient programs, product launches, late life cycle management and investigations of health care authorities. 

She is also very experienced in reviewing, drafting and negotiating industry related commercial contracts like manufacturing, supply and distribution, wholesale, co-promoting and co-marketing. 

Gertie also advices on compliance matters related to the Life Sciences industry, often linked to code of conducts and standard operating procedures on anti-corruption and anti-bribery and the industry’s self-regulation on its interactions with health care professionals.

Languages

Dutch, English, German

Memberships

  • Lector at Smelt Academy on a number of pharma related topics

Education

  • Corporate Structures, Grotius Academy for Post-Graduate Law Studies
  • Management and Economics for lawyers, Amsterdam University 
  • Dutch Law (Private and European Law), Maastricht University

Lawyer Rankings

Netherlands > Industry focus: healthcare and life sciences

(Next Generation Partners)

Gertie LintjensCMS

The team at CMS exhibits broad expertise across a diverse range of matters, including the restructuring of licenses, joint projects between pharma companies and healthcare institutions, and pricing and reimbursement negotiations. Practice head Ellen Gielen is known for her vast regulatory expertise, particularly in relation to pricing and reimbursement as well as manufacturing and distribution mandates. Judith Kok maintains a regulatory-focused practice, advising on the handling and marketing of medical devices and biocides, while Gertie Lintjens primarily advises clients in the pharma and medical device industries on early access issues and R&D projects, in addition to advertising and transparency disputes.